Loading patent…
AssigneeCommissariat A L'energie Atomique Et Aux Energies Alternatives
InventorsNicolas Gilles, Justyna Ciolek, Laura Droctove, Bernard Maillere, Herve Nozach
Estimating the term…
A peptide may include a sequence having 80% or more amino acid identity with the amino acid sequence of SEQ ID NO. 1, i.e., RPSX1CNLPVKPGPCX2GFFSAFYYSQKX3NKCHSFTYGGCAGNANRFSTX4EKCRRTC X5X6, wherein, X1 is the amino acid residue F or G, X2 is any amino acid residue, except a basic amino acid residue, X3 is the amino acid residue T or D, X4 is the amino acid residue I, L, or E, (i) X5 is V and X6 is G or (ii) X5 is G and X6 is V, and the amino acid located at position 39 is A. Such peptides may have various diagnostic and therapeutic uses.
A peptide comprising the amino acid sequence that is at least 80% identical to the amino acid sequence set forth below:
A method for detecting one or more cells expressing vasopressin-2 receptor, wherein the method comprises contacting the cell in vitro with a conjugate comprising a detectable molecule linked to a peptide comprising the amino acid sequence selected from the group consisting of SEQ ID NOs:
A method for detecting a dysregulation of vasopressin-2 receptor expression of a cell, wherein the method comprises:
Dependencies are inferred from the claim text.